The upcoming Meeting of the MedInvest Oncology Investor Conference Series will be hosted on December 14-15, 2022 in New York City.  The National Cancer Institute will be the Presenting Partner.   

​

The event will feature keynote talks, panels, and corporate presentations from over 40 companies in the cancer space.  Over 100 investors spanning venture capital, public funds, foundations, family offices and government grant making entities are expected to attend either virtually or in person.

 

Conference speakers include:

​

Gregory Simon - Former Executive Director of the Biden Cancer Initiative and White House Moonshot | Former Director of Global Policy at Pfizer

Dr. Ronan O'Hagan - President and CEO of Bectas Therapeutics | Former CSO Xilio Therapeutics | Former Director Oncology Drug Development at Merck

Dr. Adiyta Bardia - Director of the Breast Cancer Research Program, Harvard/Mass General

Dr. Neil Iyengar - Leading Expert in the Cross-Section of Diabetes and Obesity with Cancer | Medical Oncologist, Memorial Sloan Kettering Cancer Center

Dennis Purcell - Founder, Aisling Capital

Rick Lipkin - Founder, Catalytic Impact Foundation | Partner, Easton Capital

Steven Ferguson - Deputy Director, Licensing and Entrepreneurship, National Institutes of Health

Dr. Michael Salgaller - Director of Tech Transfer, NCI | Supervisor, Invention Development and Marketing Unit (IDMU) 

Dr. Alfred Slanetz - CEO Geneius Biotechnology | Former CEO, Bluebird Bio | Former Director of New Production Development, Genetech

​

​

To register for the conference, please go HERE.